Because tau is considered a mediator of neurodegeneration in AD synergistic to amyloid,16, 17 higher tau concentrations among those with CAA might be indicative of the comorbid AD pathology, which is known to frequently co‐occur with CAA.18 Here, MAPT is linked to Alzheimer disease.